CG Capital

Name

CG Capital

Legal name

CG Capital

Website

https://cg.capital

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Investor Relations & Capital Markets Advisory

NAICS

Investment Banking and Securities Intermediation (523150), Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282), Security Brokers, Dealers & Flotation Companies (6211)

akta.pro primary industry

Corporate Finance & Capital Advisory (BPAHADAB)

akta.pro secondary industries

Capital Raising Advisory (Debt/Equity/Private Capital) (BPAHADAG), Equity Capital Advisory (Private Equity Placements, Growth Capital) (BPAHAOAE), Capital Markets Advisory (IPO Readiness, SPAC, ECM/DCM Advisory) (BPAHAOAL)

Keywords

• Investor relations services
• Capital markets advisory
• IPO advisory
• Investor targeting
• Equity research coverage

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Capital Markets Advisory Services: CG Capital generates revenue through professional services fees for investor relations consulting, capital markets development programs, IPO advisory, and transaction advisory services. The firm works directly with management teams to enhance investor visibility and execute capital-raising initiatives.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

CG Capital is a capital markets development firm that enhances investor awareness for public and pre-IPO small-cap and micro-cap companies (primarily under $500M market cap, with a strong healthcare focus). It delivers Capital Markets Development (CMD) programs that combine investor relations strategy, behavioral investor targeting via a database of 1,600+ sub-$1B institutional and family office investors, IPO and M&A transaction advisory, and milestone-driven media and digital amplification. Senior professionals work directly with management teams to handle day-to-day investor communications and connect underfollowed companies with investors actively seeking overlooked value.

Product overview

CG Capital is a capital markets development firm offering a unified suite of investor relations and capital markets services. The core offering consists of Capital Markets Development (CMD) Programs, which encompass Investor Relations + Capital Markets Strategy, Investor Targeting & Outreach (powered by a database of 1,600+ sub-$1B investors), IPO + Transaction Advisory, and InvestorMedia + Digital Amplification. These services are supported by features including Targeted Analytics, Equity Research Reports for micro-cap companies, and Frontline Investor Management. The portfolio works together to provide end-to-end investor visibility, from strategic positioning and messaging to outreach and relationship management.

Differentiator

Problem solved

Functional benefit

Products and services

• Capital Markets Development (CMD) Programs
• Investor Relations + Capital Markets Strategy
• Investor Targeting & Outreach
• IPO + Transaction Advisory
• InvestorMedia + Digital Amplification

Quantifiable outcome

• $500M+ in direct capital-raising contributions by founder Rich Cockrell
• +2 more outcomes

Named customers9 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• IHG Hotels & ResortsflagshipStrategic or Co-development Partner · 20 October 2025CG Capital partnered with IHG Hotels & Resorts as the development partner for InterContinental Residences Bangkok Asoke, the first standalone InterContinental branded residences project globally. The development features 88 luxury residential units in Bangkok's Central Business District, scheduled for completion in 2029. This partnership marks IHG's entry into the global standalone branded residential market and positions Thailand (where CG Capital/Central Group operates) as a key growth market, with Thailand accounting for 23% of Asia Pacific branded residential activity.

Scale indicators3 records

Recent moves3 records

Expansion highlights3 records

Direct peers

• Solebury Trout: Investor relations and capital markets advisory firm serving small- and mid-cap public companies, including healthcare. Directly comparable to CG Capital in service mix (IR, capital raising, IPO advisory) and target client profile. Director Joy Willis previously held a leadership role at Solebury Trout, underscoring direct overlap.
• LifeSci Advisors: Specialist investor relations and capital markets advisory firm focused on the life sciences and healthcare sectors, including small/micro-cap biotech and medtech. Grant Weingarten previously worked at LifeSci Advisors, confirming direct comparability in both service offering and customer segment.
• KCSA Strategic Communications: Full-service investor relations and public relations firm with strong healthcare exposure, providing IR, capital markets, and corporate communications to public and pre-IPO companies. Joy Willis held a leadership role at KCSA, making it a directly comparable peer in scope and clientele.
• ICR (Healthcare/formerly Westwicke): ICR's healthcare practice (built on the Westwicke acquisition) is one of the largest specialist healthcare IR and capital markets advisory firms, serving small- and mid-cap biotech, medtech, and life sciences companies. Closest scaled peer to CG Capital's healthcare IR focus.
• Burns McClellan: Healthcare-specialist investor relations and corporate communications firm focused on biotech, pharmaceutical, and medtech issuers. Directly comparable given shared healthcare vertical, small/mid-cap client focus, and IR-led service offering.
• The Blueshirt Group: Investor relations and capital markets advisory firm serving technology and healthcare companies, with strong small- and mid-cap exposure. Comparable to CG Capital in service mix (IR strategy, targeting, IPO support) and senior-led engagement model.
• Rx Communications Group: Specialist investor relations and corporate communications firm for emerging biotech and specialty pharma companies. Directly comparable niche competitor targeting the same sub-$500M healthcare client base.
• Tiberend Strategic Advisors: Boutique strategic communications and IR firm focused on biotech, life sciences, and emerging growth companies. Comparable in boutique scale, healthcare vertical focus, and senior-led service model.
• Alliance Advisors IR (formerly Alliance IR/PR): Investor relations firm providing strategic IR, ESG advisory, and shareholder communications to small- and mid-cap public companies. Comparable service mix and target market to CG Capital's small-cap IR programs.

Broad incumbents

• FGS Global: One of the largest global strategic communications and investor relations advisory firms, formed from the merger of Finsbury, Glover Park, Hering Schuppener and Sard Verbinnen. Broader incumbent with capital markets advisory capabilities overlapping CG Capital's IPO and transaction advisory work, but at much larger scale and broader sector coverage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cgcapital
• Xx.com/cgcap1tal

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CG Capital